Marshall & Sullivan Inc Embecta Corp. Transaction History
Marshall & Sullivan Inc
- $200 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding EMBC
# of Institutions
411Shares Held
56.8MCall Options Held
345KPut Options Held
68.7K-
Black Rock Inc. New York, NY9.19MShares$134 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$79.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO5.19MShares$75.5 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$47.2 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.62MShares$38.1 Million0.69% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $842M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...